Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Overexpression of RAD50 is the Marker of Poor Prognosis and Drug Resistance in Breast Cancer Patients.

Current cancer drug targets - 1 Jan 2021

Karamat Uzma, Ejaz Samina

Abstract excerpt

BACKGROUND: The prevalence of breast cancer is increasing at an alarming rate and thus demands exploration of the most relevant diagnostic biomarkers. RAD50 is a cancer susceptibility gene that encodes a DNA damage repairing protein. Its role in breast cancer as clinico-pathological specific biomarker has yet to be explored. OBJECTIVE: This study was aimed to investigate the RAD50 expression and its promoter's...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acid Anhydride Hydrolases
Share to Antineoplastic Agents
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to DNA-Binding Proteins

Share to Drug Resistance, Neoplasm

Share to Pharmacogenetics

Share to Prognosis

Source

Identifiers

PMID: 33038913
DOI: 10.2174/1568009620666201009125507

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Overexpression of RAD50 is the Marker of Poor Prognosis and Drug Resistance in Breast Cancer Patients.PMID 33038913Read ↗

High RAD51 Gene Expression is Associated with Aggressive Biology and with Poor Survival in Breast CancerSemantic proximity Read ↗

Comprehensive Analysis of Prognostic and Immune Infiltrates for RAD51 in Human Breast Cancer.Semantic proximity Read ↗

Comprehensive Analysis of the Expression and Prognosis for RAD51 Family in Human Breast CancerSemantic proximity Read ↗

Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response proteinSemantic proximity Read ↗

A Pan-Cancer Bioinformatic Analysis of RAD51 Regarding the Values for Diagnosis, Prognosis, and Therapeutic PredictionSemantic proximity Read ↗

Polymorphic Variants in 5'-UTR Regions of the RAD51 Gene are Associated With RAD51 Expression and Triple-Negative Breast Cancer (TNBC): A Case-Control Study.Semantic proximity Read ↗

A multidimensional analysis of RAD1 as an immunological and prognostic biomarker in BRCASemantic proximity Read ↗

Aberrant Regulation of RAD51 Promotes Resistance of Neoadjuvant Endocrine Therapy in ER-positive Breast CancerSemantic proximity Read ↗

Role of MRE11 in DNA damage repair pathway dynamics and its diagnostic and prognostic significance in hereditary breast and ovarian cancerSemantic proximity Read ↗

Genetic interactions between INPP4B and RAD50 is prognostic of breast cancer survival.Semantic proximity Read ↗

CtBP1 transactivates RAD51 and confers cisplatin resistance to breast cancer cellsSemantic proximity Read ↗

Bi-allelic alterations in DNA repair genes underpin homologous recombination DNA repair defects in breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.